SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harvey Allen who wrote (305)8/22/1996 11:53:00 AM
From: brent groh   of 4342
 
PRLN Press Release 8-22-96

PRLN annouced today that they have improved the system for modeling the way HIV-1
kills certain immune system cells.
The model will help explain how HIV-1 destroys T-cells and lay the foundation
for a new generation of AIDS drugs.
The new model also shows how PRLN's PN355 compound demonstrates activity against
HIV-1 killing of T-cells. PRLN says its system has identified additional compounds
that act on the HIV-1 killing pathway.

Sounds like great news. Bring on $5.00 and more!!!!

Brent
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext